167 related articles for article (PubMed ID: 19194559)
1. The heme oxygenase-1 genotype is a risk factor to renal impairment of IgA nephropathy at diagnosis, which is a strong predictor of mortality.
Chin HJ; Cho HJ; Lee TW; Na KY; Yoon HJ; Chae DW; Kim S; Jeon US; Do JY; Park JW; Yoon KW; Shin YT; Lee KW; Na KR; Cha DR; Kang YS;
J Korean Med Sci; 2009 Jan; 24 Suppl(Suppl 1):S30-7. PubMed ID: 19194559
[TBL] [Abstract][Full Text] [Related]
2. Heme oxygenase-1 gene promoter polymorphism is associated with risk of gastric adenocarcinoma and lymphovascular tumor invasion.
Lo SS; Lin SC; Wu CW; Chen JH; Yeh WI; Chung MY; Lui WY
Ann Surg Oncol; 2007 Aug; 14(8):2250-6. PubMed ID: 17520317
[TBL] [Abstract][Full Text] [Related]
3. Short (GT) ( n ) repeats in heme oxygenase-1 gene promoter are associated with lower risk of coronary heart disease in subjects with high levels of oxidative stress.
Chen M; Zhou L; Ding H; Huang S; He M; Zhang X; Cheng L; Wang D; Hu FB; Wu T
Cell Stress Chaperones; 2012 May; 17(3):329-38. PubMed ID: 22120665
[TBL] [Abstract][Full Text] [Related]
4. Association of functional haem oxygenase-1 gene promoter polymorphism with polycystic kidney disease and IgA nephropathy.
Courtney AE; McNamee PT; Heggarty S; Middleton D; Maxwell AP
Nephrol Dial Transplant; 2008 Feb; 23(2):608-11. PubMed ID: 18045827
[TBL] [Abstract][Full Text] [Related]
5. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
[TBL] [Abstract][Full Text] [Related]
6. Association of a T-cell receptor constant alpha chain gene polymorphism with progression of IgA nephropathy in Japanese patients.
Deenitchina SS; Shinozaki M; Hirano T; Ando T; Hirakata H; Kiyohara Y; Katafuchi R; Fujishima M
Am J Kidney Dis; 1999 Aug; 34(2):279-88. PubMed ID: 10430975
[TBL] [Abstract][Full Text] [Related]
7. Heme oxygenase-1 promoter polymorphism is associated with risk of malignant mesothelioma.
Murakami A; Fujimori Y; Yoshikawa Y; Yamada S; Tamura K; Hirayama N; Terada T; Kuribayashi K; Tabata C; Fukuoka K; Tamaoki T; Nakano T
Lung; 2012 Jun; 190(3):333-7. PubMed ID: 22271370
[TBL] [Abstract][Full Text] [Related]
8. Length polymorphism in heme oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients.
Lin CC; Yang WC; Lin SJ; Chen TW; Lee WS; Chang CF; Lee PC; Lee SD; Su TS; Fann CS; Chung MY
Kidney Int; 2006 Jan; 69(1):165-72. PubMed ID: 16374439
[TBL] [Abstract][Full Text] [Related]
9. Length polymorphism in heme oxygenase-1 and cardiovascular events and mortality in hemodialysis patients.
Chen YH; Hung SC; Tarng DC
Clin J Am Soc Nephrol; 2013 Oct; 8(10):1756-63. PubMed ID: 23813560
[TBL] [Abstract][Full Text] [Related]
10. GT-repeat polymorphism in the heme oxygenase-1 gene promoter is associated with cardiovascular mortality risk in an arsenic-exposed population in northeastern Taiwan.
Wu MM; Chiou HY; Chen CL; Wang YH; Hsieh YC; Lien LM; Lee TC; Chen CJ
Toxicol Appl Pharmacol; 2010 Nov; 248(3):226-33. PubMed ID: 20708634
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphism of vascular endothelial growth factor: impact on progression of IgA nephropathy.
Chow KM; Szeto CC; Lai FM; Poon P; Wong TY; Li PK
Ren Fail; 2006; 28(1):15-20. PubMed ID: 16526314
[TBL] [Abstract][Full Text] [Related]
12. Shorter GT repeat polymorphism in the heme oxygenase-1 gene promoter has protective effect on ischemic stroke in dyslipidemia patients.
Bai CH; Chen JR; Chiu HC; Chou CC; Chau LY; Pan WH
J Biomed Sci; 2010 Feb; 17(1):12. PubMed ID: 20175935
[TBL] [Abstract][Full Text] [Related]
13. A candidate gene approach to genetic contributors to the development of IgA nephropathy.
Yamamoto R; Nagasawa Y; Shoji T; Katakami N; Ohtoshi K; Hayaishi-Okano R; Yamasaki Y; Yamauchi A; Tsubakihara Y; Imai E; Rakugi H; Isaka Y
Nephrol Dial Transplant; 2012 Mar; 27(3):1020-30. PubMed ID: 21737517
[TBL] [Abstract][Full Text] [Related]
14. Association of heme oxygenase-1 GT-repeat polymorphism with blood pressure phenotypes and its relevance to future cardiovascular mortality risk: an observation based on arsenic-exposed individuals.
Wu MM; Chiou HY; Chen CL; Hsu LI; Lien LM; Wang CH; Hsieh YC; Wang YH; Hsueh YM; Lee TC; Cheng WF; Chen CJ
Atherosclerosis; 2011 Dec; 219(2):704-8. PubMed ID: 21945498
[TBL] [Abstract][Full Text] [Related]
15. Serum bilirubin and ferritin levels link heme oxygenase-1 gene promoter polymorphism and susceptibility to coronary artery disease in diabetic patients.
Chen YH; Chau LY; Chen JW; Lin SJ
Diabetes Care; 2008 Aug; 31(8):1615-20. PubMed ID: 18443197
[TBL] [Abstract][Full Text] [Related]
16. Association between GT-repeat polymorphism at heme oxygenase-1 gene promoter and gastric cancer and metastasis.
Motovali-Bashi M; Hamidy M
Tumour Biol; 2015 Jun; 36(6):4757-62. PubMed ID: 25956277
[TBL] [Abstract][Full Text] [Related]
17. Association Between Heme Oxygenase-1 Promoter Polymorphisms and the Development of Albuminuria in Type 2 Diabetes: A Case-Control Study.
Lee EY; Lee YH; Kim SH; Jung KS; Kwon O; Kim BS; Nam CM; Park CS; Lee BW; Kang ES; Cha BS; Lee HC
Medicine (Baltimore); 2015 Oct; 94(43):e1825. PubMed ID: 26512585
[TBL] [Abstract][Full Text] [Related]
18. Genotype and allele frequencies of heme oxygenase-1 promoter region in a Greek cohort.
Katana EP; Skoura LG; Scouras ZG; Daniilidis MA
Chin Med J (Engl); 2011 Oct; 124(20):3408-11. PubMed ID: 22088544
[TBL] [Abstract][Full Text] [Related]
19. Association of susceptibility to the development of pneumonia in the older Japanese population with haem oxygenase-1 gene promoter polymorphism.
Yasuda H; Okinaga S; Yamaya M; Ohrui T; Higuchi M; Shinkawa M; Itabashi S; Nakayama K; Asada M; Kikuchi A; Shibahara S; Sasaki H
J Med Genet; 2006 Apr; 43(4):e17. PubMed ID: 16582079
[TBL] [Abstract][Full Text] [Related]
20. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients.
Chen YH; Lin SJ; Lin MW; Tsai HL; Kuo SS; Chen JW; Charng MJ; Wu TC; Chen LC; Ding YA; Pan WH; Jou YS; Chau LY
Hum Genet; 2002 Jul; 111(1):1-8. PubMed ID: 12136229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
